|Articles|August 28, 2020

FDA Fronts Pivotal Life Sciences Trend in 2020

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

BySCIEX

November 10th 2025

Improving end-to-end metabolite identification by LC-MS/MS

BySCIEX

November 10th 2025

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

BySCIEX

November 10th 2025

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

BySCIEX

November 10th 2025

Targeted high resolution metabolite screening workflows

BySCIEX

November 10th 2025

FDA Fronts Pivotal Life Sciences Trend in 2020

Newsletter

Related Content

An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders

Improving end-to-end metabolite identification by LC-MS/MS

Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics

Confident characterization and identification of glucuronide metabolites using diagnostic fragments from electron activated dissociation (EAD)

Targeted high resolution metabolite screening workflows

Trending on Pharmaceutical Technology

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

PharmTech Weekly News Roundup — Week of November 10, 2025

UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report

Share Your Perspective on the Commissioner’s National Priority Vouchers Program